randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als Erythropoietin in amyotrophic lateral sclerosis:

Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry Randomized, Controlled Trials Circulation In the randomized, double blind, placebo controlled, global Phase III trial recently presented in the ASCO 2024 annual meeting, consolidation treatment with #durvalumab significantly improved clinical outcomes for patients with limited stage small cell Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis ScienceDirect Frontiers Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments

SKU: 94808343147 · From aimoneimmobiliare.it